```
[Federal Register Volume 79, Number 67 (Tuesday, April 8, 2014)]
[Notices]
[Page 19339]
From the Federal Register Online via the Government Printing Office [http://www.gpo.gov/]
[FR Doc No: 2014-07783]



[[Page 19339]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2014-0003]


Draft Guideline--Centers for Disease Control and Prevention Draft 
Guideline for the Prevention of Surgical Site Infections

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (DHHS).

ACTION: Reopening of public comment period.

-----------------------------------------------------------------------

SUMMARY: On January 29, 2014 the Centers for Disease Control and 
Prevention (CDC), located within the Department of Health and Human 
Services (HHS) published a notice in the Federal Register requesting 
public comment on the Draft Guideline for the Prevention of Surgical 
Site Infections (SSIs) (draft Guideline) (79 FR 4724). Written comments 
were to be received on or before February 28, 2014. Some commenters 
requested additional time to review the guideline and provide comments. 
In consideration of these requests, HHS/CDC is reopening the comment 
period for 30 days.

DATES: Comments must be received on or before May 8, 2014.

ADDRESSES: You may submit comments, identified by CDC-2014-0003, by any 
of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov/. 
Follow the instructions for submitting comments.
     Mail: Division of Healthcare Quality Promotion, National 
Center for Emerging and Zoonotic Infectious Diseases, Centers for 
Disease Control and Prevention, Attn: Guideline for the Prevention of 
Surgical Site Infections Docket No. CDC-2014-0003, 1600 Clifton Rd. 
NE., Mailstop A07, Atlanta, Georgia, 30333.
    Instructions: All submissions received must include the agency name 
and docket number or RIN. All relevant public comments received will be 
posted publicly to http://www.regulations.gov/ without change, including any 
personal or proprietary information provided. To download an electronic 
version of the draft Guideline and appendices, access http://www.regulations.gov/.
    Written materials identified by Docket No. CDC-2014-0003 will be 
available for public inspection Monday through Friday, except for legal 
holidays, 9 a.m. until 4:30 p.m. Eastern Standard Time, at CDC Library, 
1600 Clifton Road NE., Atlanta, Georgia, 30333. Please call ahead to 
(404) 639-1717 and request a Library representative schedule your 
visit. All public comments will be reviewed and considered prior to 
finalizing the draft Guideline.

FOR FURTHER INFORMATION CONTACT: Erin Stone, Division of Healthcare 
Quality Promotion, National Center for Emerging and Zoonotic Infectious 
Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., Mailstop A-31, Atlanta, Georgia, 30333; Telephone: (404) 639-4000.

SUPPLEMENTARY INFORMATION: The draft Guideline addresses new and 
updated strategies for the prevention of SSI in healthcare settings. 
This draft Guideline can be found at http://www.regulations.gov/ Docket 
No. CDC-2014-0003.
    CDC also published the supporting appendices that include primary 
evidence, study evaluation, and data evaluation tables that were used 
in developing the draft Guideline recommendations.
    The draft Guideline is designed for use by infection prevention 
staff, healthcare epidemiologists, administrators, nurses, and 
personnel responsible for developing, implementing, and evaluating 
infection prevention and control programs for healthcare settings 
across the continuum of care. The recommendations contained in the 
draft Guideline are based on a targeted systematic review of the best 
available evidence for specific topics related to the prevention of 
surgical site infections (SSI).
    Since 2010 CDC has collaborated with national partners, 
academicians, public and private health professionals, and other 
partners to create this draft Guideline. Additionally, CDC sought input 
in each phase of development from subject matter experts in surgery, 
infectious diseases, and orthopedics through a Guideline Expert Panel 
formed to develop the new draft Guideline. CDC also received input from 
the Healthcare Infection Control Practices Advisory Committee (HICPAC) 
throughout the development of the draft Guideline. HICPAC includes 
representatives from public health, infectious diseases, regulatory and 
other federal agencies, professional societies, and other stakeholders. 
This new draft Guideline will not be a federal rule or regulation.

    Dated: April 3, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-07783 Filed 4-7-14; 8:45 am]
BILLING CODE 4163-18-P
```